Skip to content
Steady
Get Steady
ScienceJune 15, 20263 min read

Most women who stop a GLP-1 end up back on it. New data shows just how common that is.

A study of 60,000 patients found that about 40% stopped their GLP-1 within a year, but most started again soon after: 42% within a year, nearly 60% within two. The weight tends to come back, and so do they.

What happened

New research presented at ENDO 2026, the Endocrine Society's annual meeting, looked at insurance records for 60,000 people on GLP-1 medications and asked a simple question: when people stop, do they stay stopped?

Mostly, no. About 40% had stopped within the first year, and nearly 60% within two. But a large share came back: 42% restarted within a year, and 58% within two. The pattern is clear. For most people, stopping is not the end of the story. It is a pause, usually followed by a return, very often because the weight came back.

Why the weight returns

This is not a failure of willpower, and it is worth saying plainly. Obesity behaves like a chronic condition, and these drugs treat it while you take them. They work by changing appetite signals. Stop the signal, and for most people appetite returns to where it was, and so does some of the weight. Studies tracking people after they quit have found a meaningful share of the lost weight returns within 12 to 18 months.

That is biology, not weakness. But it has a hard edge for women specifically, and it is about what comes back.

The part the headline misses

When you lose weight, some of it is muscle. When you regain weight after stopping, you tend to regain fat, not the muscle you lost. Do that across a few stop-start cycles and the body composition quietly shifts the wrong way: less muscle, more fat, at the same number on the scale.

So the lesson is not "never stop." Sometimes a pause is the right medical call, and that belongs with your doctor. The lesson is that the muscle you protect while you are on the drug is what carries you through any time off it. The stronger you build the foundation now, the less a pause costs you.

What it means for you

Two practical things follow.

First, treat your time on a GLP-1 as the moment to build, not just to shrink: protein, two short strength sessions a week, consistency. That foundation is what holds when the appetite signal is not there to help you. (See why muscle is the number that matters.)

Second, if you and your prescriber ever do plan a pause, plan it deliberately, the way you would taper anything that works. Our piece on what happens when you stop a GLP-1 walks through how to do it with the least regain.

What Steady does with this

This is the long game, and it is exactly what Steady is built for. The drug is one chapter. Your muscle, your habits, and your data are the through-line.

  • Steady protects your muscle and protein while you are on the drug, so a future pause costs you less.
  • It keeps an unbroken record of your weight, dose and symptoms, so if you stop and restart, you and your prescriber are working from your real history, not a memory.
  • It treats your year as a trend, not a finish line, which is how these medicines actually work.

The scale going down is the easy part. Holding what you built, on the drug and off it, is the part that matters. That is the part Steady was made for.

Read the originalEndocrine Society (ENDO 2026)Open
Go deeper

The news changes weekly. What protects your body doesn't.

Steady is the daily companion for women on a GLP-1: protein, muscle, symptoms and cycle, in one place. Free on the App Store.

Free to start. Subscription unlocks the full app. iPhone only.

More from the Brief